Skip to main content
Updating results

Stem Cells

The $21 million facility, next to the company's headquarters at University Research Park, will meet the Food and Drug Administration’s strict requirements for Good Manufacturing Practice. It will be at least 1,000 times cleaner than a regular lab, allowing production of cells for clinical trials.

  • 8 min to read

Dr. David Gamm is one of about 100 faculty researchers using stem cells to model diseases, screen drugs or develop cell therapies at UW-Madison, where James Thomson gained international attention 20 years ago this month by announcing the world’s first isolation of human embryonic stem cells.

Ten years after UW-Madison's James Thomson's groundbreaking co-discovery of iPS cells (stem cells created without destroying embryos), we look at what has been done with these cells so far and what might be coming next.

The stem cell company says it will keep its headquarters in Madison and set up a small manufacturing facility nearby.

Get up-to-the-minute news sent straight to your device.

Topics

News Alerts

Badger Sports

Breaking News

Crime

Politics